The WHO has adopted revised recommendations for International Biological Reference Standards (WHO IBRS), introducing updated guidance on commutability, calibration, secondary standards and International Units. Learn what IVD and biological product manufacturers need to know.

AI in healthcare has transformative potential, but it also raises ethical and regulatory challenges. The WHO has published guidelines on the governance of AI, with a focus on large-scale multimodal models (LMMs). These systems can revolutionize medical diagnosis, scientific research and drug development, but it is essential to guarantee data security, transparency of algorithms and equity of access.